Mercury Pharmaceuticals

13

May 2026

Semaglutide significantly reduces obesity in treatment-resistant young adults

A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based non-pharmacological obesity care during childhood, according to a randomized controlled trial being presented at this year's European Congress on Obesity (ECO) in Istanbul, Turkey (12-15 May).

READ MORE

13

May 2026

Adult weight gain strongly linked to higher obesity-related cancer risk

New research presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity related cancers.

READ MORE

13

May 2026

GLP-1 obesity drugs mainly reduce fat while preserving muscle mass

New research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass is preserved.

READ MORE

13

May 2026

Expert questions benefits of new UK drug approval pathway

A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today.

READ MORE

13

May 2026

Tranexamic acid modestly reduces bleeding after cesarean delivery in women

Giving tranexamic acid to women with placenta praevia (when the placenta covers the cervical opening) undergoing cesarean birth leads to a significant yet modest reduction in severe bleeding after delivery with no evidence of an increase in serious adverse events, finds a trial from China published by The BMJ today.

READ MORE

13

May 2026

Study reveals hidden struggles faced by unaccompanied child refugees

​From relentless cycles of intrusive memories to loneliness and physical pain - a new study form the University of East Anglia reveals the struggles of refugees who entered the UK as unaccompanied minors.

READ MORE

13

May 2026

Brain-controlled hearing aid concept helps solve the cocktail party problem

Researchers developed a real-time brain-controlled hearing system that uses neural signals to identify and amplify the speaker a listener is focusing on in noisy, multi-talker environments. Using intracranial brain recordings, the system improved speech intelligibility, reduced listening effort, tracked attention shifts, and provided a benchmark for future brain-guided hearing aids.

READ MORE

13

May 2026

New trial aims to improve ATTR-CM diagnosis in heart failure

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart failure, particularly among older adults.

READ MORE

13

May 2026

Too little or excessive sleep may accelerate organ aging

An analysis of biological clocks throughout the human body suggests that too few hours of sleep-and too many-may speed aging in the brain, heart, lung, and immune system and is associated with a wide range of diseases.

READ MORE

13

May 2026

Scientists identify genetic mechanisms connected to core autism behaviors

A long‑overlooked stretch of the human genome appears to play a distinct role in shaping the social and stereotypic repetitive behaviors that define Autism Spectrum Disorder (ASD), without affecting learning or other cognitive abilities, according to a major new study published in Nature.

READ MORE